Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Exercise Therapy × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Breast 1

Conditions

Breast Neoplasms 11 Motor Activity 6 Fatigue 2 Depression 2 Breast Cancer Lymphedema 2 Ventricular Dysfunction, Left 1 Triple Negative Breast Neoplasms 1 Pain 1 Neurotoxicity Syndromes 1 Neoplasms 1 Lymphedema 1 Kinesiophobia 1 Heart Failure, Systolic 1 Chronic Pain 1 Body Weight Changes 1 Anxiety Disorders 1 Agnosia 1

Interventions

Paclitaxel 24 pembrolizumab 22 Docetaxel 20 Capecitabine 18 Trastuzumab 16 Fulvestrant 14 Cyclophosphamide 14 Lapatinib 13 Anastrozole 12 Letrozole 10 Carboplatin 10 Therapeutics 9 Radiotherapy 9 Doxorubicin 9 Exercise 8 Cisplatin 8 Blood Specimen Collection 8 palbociclib 7 Nivolumab 7 Gemcitabine 7 Bevacizumab 7 liposomal doxorubicin 6 exemestane 6 Vinorelbine 6 Tamoxifen 6 Fluorouracil 6 atezolizumab 5 abemaciclib 5 Methods 5 Irinotecan 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04877860 2023-05-09

PaiNEd

Universidad de Granada

Phase NA Unknown

Agnosia, Breast Neoplasms, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡